Introduction
Drug-induced gingival overgrowth (GO) is an unwanted side effect that has been mainly associated with chronic therapy with phenytoin, nifedipine and cyclosporin (CsA). This condition is characterized by gingival enlargement due to alterations in cellular and extracellular matrix (ECM) metabolisms, leading to accumulation of several components of ECM. [1] [2] However, the inducing molecular mechanisms remain unknown in many aspects.
The development of GO involves changes in the metabolism of several cellular types, in a complex interdependent reaction in cascade. [2] [3] [4] However, fibroblasts have been the main cell studied, as they are responsible for the synthesis and enzymatic degradation of ECM proteins. 3, [5] [6] [7] [8] [9] Fibroblasts derived from phenytoin-induced GO exhibit higher proliferative activity 10 and elevated levels of collagen synthesis 11 compared with cells obtained from normal gingiva.
This fact raised the hypothesis that phenytoin exerts a selective pressure favoring the proliferation of a specific fibroblastic subpopulation, which eventually becomes the predominant cell type in the tissue.
Ultrastructural analysis of "modified" fibroblasts of GO induced by phenytoin showed morphological features compatible with myofibroblasts. 12 Myofibroblast is considered the main cellular type involved in extracellular matrix deposition during tissue remodeling. This cell population is characterized by the expression of α-smooth muscle actin (α-SMA).
After the completion of physiological events, such as wound healing, the reversion of myofibroblasts does not seem to be possible, and massive apoptosis has been described. 13 
Material and methods
The experimental protocol of this study was 
Results

Clinical observations
The experimental period elapsed without any intercurrence. No clinical or behavioral modification that could be attributed to drug administration or its systemic side effects was observed.
At the initial phase (control group), subtle signs of gingival inflammation were observed, usually limited to the free gingival margins.
Gingival enlargement was observed in all animals, In vitro studies with gingival fibroblasts described an increase in α-SMA expression induced by CsA, associated with the upregulation of TGF-β1 gene expression. 19 This cytokine is a potent inducing factor for myofibroblast transdifferentiation 13 and protects them from apoptosis. 14 Parallelly, in vivo studies found 
